The UCLA Cardiovascular Diseases Fellowship is pleased and privileged to offer an international fellowship exchange program with the Zhejiang University School of Medicine (SAHZU) in Hangzhou, China. Fellows who are interested in participating will spend approximately 2-4 weeks rotating at SAHZU’s main and satellite hospitals in a predominantly procedural environment, in a high volume patient setting with exposure to advanced interventional and electrophysiology technologies in a Chinese urban setting. This is a unique cultural opportunity to participate in a health care setting in the most populated country in the world, and witness different patterns of practice and patient care within the realm of cardiovascular disease.
SAHZU traces its roots back to 1869 when it was originally opened as an Opium Refuge, managed by Dr. Meadows from the Church Missionary Society. It later changed its name to “Guang Ji”, or “spreading benevolence and saving people”, and was managed by Dr. Duncan Main, a Scottish missionary doctor. Its first iteration of a medical school, the University Benevolence Medical School was founded in 1885. It was officially named a government hospital in 1952 and the Department of Cardiology was founded in 1989 with interventional cardiology capacity.
SAHZU’s Department of Cardiology has approximately 45 cardiologists serving as clinical staff, headed by Dr. Jian-an Wang, M.D., Ph.D., who also serves as President of the Hospital. The Department’s co-directors include Dr. Mei-Xiang Xiang, Dr. Ji Ma, Dr. Young Sun, and Dr.Jun Jiang. The hospital includes a CCU unit, and 3 cardiology ward beds, with a total of 162 inpatient beds. There are also satellite medical centers, including a Binjiang Branch which also has a cardiac catheterization lab, a CCU, and a general cardiology ward. In 2014, their outpatient clinics saw over 150,000 patients. Their catheterization lab perform over 6000 procedures yearly. SAHZU also is a leading center in complex coronary interventions, structural heart disease (ie transcatheter aortic valve replacement and mitral valve repair) both locally and nationally within China. Their Interventional Center also engages in clinical trials related to percutaneous left atrial appendage closure, stem cell transplantation, and bio-absorbable stent interventions. The Department is also heavily invested in basic science research (ie gene polymorphisms, stem cell therapies, etc). with an animal lab and clinical research center, with publications frequently being published both in Chinese and international cardiology journals.
SAHZU has already initiated Faculty/Fellow exchanges with UCLA with other Departments, including Orthopedics, Neurosurgery, Anesthesiology, and Surgery, and engages regularly via teleconferences with UCLA’s Department of Pathology, Surgery, and Thoracic Radiology. They also have collaborated with other American academic institutions as well as universities in Canada and Germany.
Hangzhou is the capital and the largest city of Zheijang province, one of the ancient capitals of China. The prefecture under which Hangzhou resides consists of approximately 8.7 million people (2010 census), and is the 4th largest metropolitan area in China (21 million people in 2010). It has been long known as an economic and tourist hub since dynasty time, visited by Marco Polo in the 13th century and described as “greater than any [city] in the world”, and Ibn Battuta in the 14th century described it as the “the biggest city I have ever seen on the face of the earth”. Hangzhou’s Hi-Tech Industrial Development Zone is considered the “Silicon Valley” of China, and it is headquarters to Alibaba, the largest IPO in the world. In line with its rich dynasty heritage, it is home to West Lake and is the southern terminus of the Grand Canal, both of which are UNESCO World Heritage Sites. It also is approximately an hour train ride to Shanghai.
The Second Affiliated Hospital, Zhejiang University College of Medicine (SAHZU) will provide a 2 to 4 week training and cultural exchange program for cardiology fellows from UCLA in cardiovascular interventions. The goal of this rotation exchange is to provide exposure to different systems of care to provide global perspectives on differences in cardiovascular care in different health care settings across different countries. This rotation will be available for senior level fellows (PGY-5+) who have already attained competency in cardiac catheterization skills for a cultural immersion experience in a predominantly procedural based rotation at an extremely high volume tertiary referral center in a major urban setting that is Hangzhou, China.
Fellows will be involved in the following during their rotation at SAHZU and their satellite affiliated institutions:
Transradial coronary intervention
Imaging and physiology guided PCI
Rotational atherectomy for calcified coronary lesions
Antegrade and Retrograde approach for complex CTO lesions
Stereotaxis catheter ablation for complex tachyarrhythmias
Pacemaker, CRT or ICD implantation
Other miscellaneous coronary, structural, or electrophysiologic interventions
Non Clinical Activities
Living arrangements will be arranged by SAHZU either on campus or near the hospital with basic amenities. Depending on availability, a stipend may also be provided for living costs while living in Hangzhou. Transportation to and from the airport will be arranged with SAHZU International Affairs Staff.
It is the fellow’s responsibility to arrange for his/her travel visa to China in a timely fashion prior to the assigned dates of his/her rotation.
Consulate General of the People’s Republic of China in Los Angeles (information on how to obtain a Visa)
Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU)
Lonely Planet’s Website on Hangzhou